CYP cynata therapeutics limited

Ann: Publication comparing Cymerus MSCs to other MSCs, page-73

  1. 4,848 Posts.
    lightbulb Created with Sketch. 344
    Sorry Bedger, but I hold an empiricist view when it comes to bio investing and I read everything I can if I have an interest.

    My postings that are cut and post don't suit your investment here and i get that, but it is a concern.

    Every term used in eradicating the tumorous concerns say "improving" or "minimising".

    These are not words that the FDA will take lightly.

    The good thing is that you have recognised that there are added complicated steps to improve or minimise the safety concerns with iPSC treatments.

    That is something that will take years, but I will watch it become acceptably safe in years to come with interest.

    Only then will you be able to provide hopeful completed proven safe data to the FDA for the battle ahead.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
-0.010(5.56%)
Mkt cap ! $38.41M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $21.40K 127.0K

Buyers (Bids)

No. Vol. Price($)
9 425750 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 90178 3
View Market Depth
Last trade - 14.06pm 13/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.